Hypertension Diagnostics Stock Market Value
Hypertension Diagnostics' market value is the price at which a share of Hypertension Diagnostics trades on a public exchange. It measures the collective expectations of Hypertension Diagnostics investors about its performance. With this module, you can estimate the performance of a buy and hold strategy of Hypertension Diagnostics and determine expected loss or profit from investing in Hypertension Diagnostics over a given investment horizon. Check out Hypertension Diagnostics Correlation, Hypertension Diagnostics Volatility and Hypertension Diagnostics Alpha and Beta module to complement your research on Hypertension Diagnostics.
| Symbol | Hypertension |
Hypertension Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hypertension Diagnostics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hypertension Diagnostics.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Hypertension Diagnostics on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Hypertension Diagnostics or generate 0.0% return on investment in Hypertension Diagnostics over 90 days. Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that... More
Hypertension Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hypertension Diagnostics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hypertension Diagnostics upside and downside potential and time the market with a certain degree of confidence.
Hypertension Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hypertension Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hypertension Diagnostics' standard deviation. In reality, there are many statistical measures that can use Hypertension Diagnostics historical prices to predict the future Hypertension Diagnostics' volatility.Hypertension Diagnostics Backtested Returns
Hypertension Diagnostics holds Efficiency (Sharpe) Ratio of -0.13, which attests that the entity had a -0.13 % return per unit of risk over the last 3 months. Hypertension Diagnostics exposes zero different technical indicators, which can help you to evaluate volatility embedded in its price movement. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Hypertension Diagnostics are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Hypertension Diagnostics has no correlation between past and present. Overlapping area represents the amount of predictability between Hypertension Diagnostics time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hypertension Diagnostics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Hypertension Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.8 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
Other Information on Investing in Hypertension Pink Sheet
Hypertension Diagnostics financial ratios help investors to determine whether Hypertension Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hypertension with respect to the benefits of owning Hypertension Diagnostics security.